<VariationArchive VariationID="56045" VariationName="NM_000170.3(GLDC):c.1444dup (p.Asp482fs)" VariationType="Duplication" Accession="VCV000056045" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2013-07-24" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70684" VariationID="56045">
      <GeneList>
        <Gene Symbol="GLDC" FullName="glycine decarboxylase" GeneID="2731" HGNC_ID="HGNC:4313" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6532467" stop="6645729" display_start="6532467" display_stop="6645729" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6532463" stop="6645691" display_start="6532463" display_stop="6645691" Strand="-" />
          </Location>
          <OMIM>238300</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000170.3(GLDC):c.1444dup (p.Asp482fs)</Name>
      <CanonicalSPDI>NC_000009.12:6592180:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6592180" stop="6592181" display_start="6592180" display_stop="6592181" variantLength="1" positionVCF="6592180" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6592180" stop="6592181" display_start="6592180" display_stop="6592181" variantLength="1" positionVCF="6592180" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>D482fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.6592182dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.6592182dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.6592182dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.6592182dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016397.1" sequenceAccession="NG_016397" sequenceVersion="1" change="g.58512dup">
            <Expression>NG_016397.1:g.58512dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000170.3" sequenceAccession="NM_000170" sequenceVersion="3" change="c.1444dup" MANESelect="true">
            <Expression>NM_000170.3:c.1444dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000161.2" sequenceAccession="NP_000161" sequenceVersion="2" change="p.Asp482fs">
            <Expression>NP_000161.2:p.Asp482fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_643" sequenceAccession="LRG_643">
            <Expression>LRG_643:g.58512dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000170.2" sequenceAccession="NM_000170" sequenceVersion="2" change="c.1444dupG">
            <Expression>NM_000170.2:c.1444dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA263298" DB="ClinGen" />
        <XRef Type="rs" ID="386833526" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000170.3(GLDC):c.1444dup (p.Asp482fs) AND Non-ketotic hyperglycinemia" Accession="RCV000049454" Version="7">
        <ClassifiedConditionList TraitSetID="3243">
          <ClassifiedCondition DB="MedGen" ID="C0751748">Non-ketotic hyperglycinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-12-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-07-24" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16450403</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16601880</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
                <XRef ID="Glycine+Encephalopathy/3115" DB="Genetic Alliance" />
                <XRef ID="237939006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycine encephalopathy</ElementValue>
                <XRef ID="MONDO:0011612" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
                <XRef ID="407" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonketotic hyperglycinemia</ElementValue>
                <XRef ID="HP:0008288" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NKH</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7219" />
                <XRef ID="7219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonketotic hyperglycinemia (NKH) is the inborn error of glycine metabolism defined by deficient activity of the glycine cleavage enzyme system (GCS), which results in accumulation of large quantities of glycine in all body tissues including the brain. Based on ultimate outcome NKH is categorized into severe NKH (no developmental progress and intractable epilepsy) and attenuated NKH (variable developmental progress and treatable or no epilepsy). The majority of children with NKH have onset in the neonatal period manifest as progressive lethargy evolving into profound coma and marked hypotonia; 85% have severe NKH and 15% attenuated NKH. Those with onset between two weeks and three months typically present with hypotonia; 50% have severe NKH and 50% attenuated NKH. Those with onset after age three months have attenuated NKH. Severe versus attenuated NKH is consistent within families, but the degree of developmental progress in those with attenuated NKH can vary.</Attribute>
                <XRef ID="NBK1357" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="407" DB="Orphanet" />
              <XRef ID="C0751748" DB="MedGen" />
              <XRef ID="MONDO:0011612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008288" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="131248" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS627" />
        <ClinVarAccession Accession="SCV000081888" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">16450403</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000170.2:c.1444dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="605899" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4076006" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000170.3:c.1444dup|Non-ketotic hyperglycinemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002075773" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000170.3:c.1444dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3107889" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4614697|MedGen:C0751748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582267" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16450403</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16601880</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with clinical features of glycine encephalopathy (PMID: 16450403). This variant is also known as c.1443insG in the literature. ClinVar contains an entry for this variant (Variation ID: 56045). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp482Glyfs*10) in the GLDC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GLDC are known to be pathogenic (PMID: 16601880).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLDC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.6592180_6592181insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3107889" TraitType="Disease" MappingType="XRef" MappingValue="C0751748" MappingRef="MedGen">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4076006" TraitType="Disease" MappingType="Name" MappingValue="Non-ketotic hyperglycinemia" MappingRef="Preferred">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131248" TraitType="Disease" MappingType="Name" MappingValue="Non-ketotic hyperglycinemia" MappingRef="Preferred">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

